Overall, T cell activation status of circulating and tumour-infiltrating T cells correlated with response to treatment and adverse tumour biology as well as levels of immunosuppressive and pro-angiogenic PIGF and VEGFA present within the TME. This evidence concerns the gene PIGF and neoplasm.